جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

66 مُخرَج نتائج البحث عن «stat»

مراجعةوصول مفتوح20262استشهاد· Semantic Scholar

Efficacy and Safety of Laser-Based Therapies for Melasma: A Systematic Review and Meta-Analysis

Cureus · مجلد 18 (3) · e106154-e106154

Melasma is a chronic acquired hyperpigmentation disorder that often exerts a psychosocial burden on affected individuals. Although laser- and light-based therapies are pivotal third-line interventions for recalcitrant cases, clinical consensus regarding their comparative efficacy and long-term safety remains inconsistent. This systematic review and meta-analysis aimed to evaluate and synthesize evidence from randomized controlled trials (RCTs) on the efficacy and safety of various laser-based therapies for melasma. A literature search was performed using PubMed, Excerpta Medica Database (EMBASE), Cochrane Library, and Web of Science databases from inception to January 2026. RCTs and split-face comparative studies evaluating laser therapies versus placebo, topical agents, or alternative laser modalities were included. Data synthesis was performed using a random-effects model with Hartung-Knapp adjustment. The primary outcome was the mean difference (MD) in the reduction of the Melasma Area and Severity Index (MASI) score. The certainty of evidence was appraised using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. Fifty-two studies, involving 1,058 participants, met the inclusion criteria. The overall pooled analysis showed a trend toward clinical improvement that was not statistically significant (MD: 0.70; 95% CI: -0.55, 1.95; p = 0.2682). Subgroup analysis by laser technology revealed that low-fluence Q-switched Nd:YAG (QSNY) (1064 nm) lasers provided a statistically significant reduction in melasma severity (MD 1.47; 95% CI: 0.08 to 2.85, p < 0.05), while picosecond lasers (MD -0.11; 95% CI: -0.79 to 0.57) and fractional lasers (MD 0.94; 95% CI: -0.84 to 2.71) did not significantly outperform control groups. Statistical heterogeneity was high across the evidence (I² = 96.2%). The overall certainty of evidence for the primary outcome was very low because of the lack of blinding and the high inconsistency. No serious adverse events were reported, although minor complications, such as transient erythema and localized burning, were common. Low-fluence QSNY laser therapy is an effective adjunctive modality for melasma management. However, due to high recurrence rates and variability in outcomes, it should be integrated into a multi-modal approach alongside strict photoprotection and topical depigmenting agents. Future research should prioritize the long-term follow-up and standardization of laser parameters across different skin phenotypes.

melasmalaser therapyQ-switched Nd:YAG laserpicosecond laser
مراجعةوصول مفتوح20262استشهاد· Semantic Scholar

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers for Cardiovascular and Renal Protection in Type 2 Diabetes: A Systematic Review and Meta-Analysis

Cureus · مجلد 18 (2) · e103029-e103029

Type 2 diabetes mellitus (T2DM) increases the risk of cardiovascular morbidity and end-stage renal disease. Renin-angiotensin-aldosterone system (RAAS) inhibitors, specifically angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are standard therapies for organ protection. However, uncertainty remains regarding their comparative efficacy and the safety of combination therapy. This systematic review and meta-analysis aimed to compare the efficacy of ACEIs versus ARBs in reducing cardiovascular and renal events in patients with T2DM and to assess the safety of dual blockade. PubMed, EMBASE, and Cochrane databases were searched for randomized controlled trials (RCTs) published up to 2025 comparing ACEIs, ARBs, or their combination against placebo or active controls in T2DM patients. The primary outcome was a composite of cardiovascular death, myocardial infarction, stroke, and renal failure. Methodological quality was assessed using the Cochrane Risk of Bias 2 tool. Data were synthesized using frequentist pairwise and Bayesian network meta-analyses. Heterogeneity was explored via meta-regression, and trial sequential analysis (TSA) was used to assess the sufficiency of evidence. In total, 16 RCTs involving 47,406 participants were included. In pairwise analysis, both ACEIs (risk ratio (RR) = 0.87, 95% confidence interval (CI) = 0.81-0.94) and ARBs (RR = 0.90, 95% CI = 0.83-0.98) significantly reduced the risk of the primary composite endpoint compared to control. Network meta-analysis showed no statistically significant difference between ACEIs and ARBs (RR = 0.98, 95% CI = 0.88-1.09). Although ACEIs ranked slightly higher in probability for reducing all-cause mortality (surface under the cumulative ranking = 78% vs. 65%), this difference was not statistically significant. Dual blockade (ACEI + ARB) increased the risk of hyperkalemia (RR = 2.8) and acute kidney injury (RR = 1.7) without improving efficacy. Meta-regression identified baseline systolic blood pressure as a significant modifier of treatment benefit (p = 0.04). TSA indicated that the evidence for the RAAS blockade's benefit is conclusive. ACEIs and ARBs exhibit comparable efficacy in preventing cardiovascular and renal events in patients with T2DM, with a marginal mortality benefit favoring ACEIs. Dual blockade is associated with increased harm and is not recommended. Monotherapy with either agent remains the preferred strategy for organ protection.

ACE inhibitorsangiotensin receptor blockerstype 2 diabetesrenin-angiotensin-aldosterone system blockade
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Clinical Presentation and Etiology of Thrombocytopenia Among Patients at a Tertiary Care Hospital in the Kingdom of Saudi Arabia

Cureus · مجلد 18 (4) · e107700-e107700

Background Thrombocytopenia is a common hematological disorder encountered in clinical practice. To improve diagnostic efficiency and patient outcomes, it is important to understand its frequent clinical manifestations and predominant etiologies in different healthcare settings. This study aimed to describe the typical clinical presentations and underlying causes of thrombocytopenia among patients at a tertiary care hospital in the Kingdom of Saudi Arabia. Study design A single-center, retrospective cross-sectional study. Materials and methods Patients with thrombocytopenia (platelet count < 150,000/microL) admitted between January and December 2022 were included. Patients with pseudothrombocytopenia were excluded. Demographic, clinical, and laboratory data were collected through manual review of electronic medical records. Etiologies were recorded, and statistical analysis was performed using Stata software. Here and throughout, n denotes the number of patients contributing data to a given comparison, and N denotes the total cohort (N = 114). Where applicable, denominators were adjusted for missing data. Results Of 114 patients, 73 (64.04%) were male. The mean age was 40.80 ± 15.93 years, and the mean length of hospital stay was 11.83 ± 15.73 days. The mean platelet count was 51,480 ± 39,690/microL. Mild thrombocytopenia was observed in 19 (16.67%) patients, moderate in 31 (27.19%), and severe in 64 (54.14%). Infection was the most common etiology (n = 48, 42.11%), with Plasmodium species accounting for the largest number of cases (n = 25). Bleeding manifestations were observed in 72 (63.07%) patients, most commonly epistaxis (n = 16, 14.04%), ecchymosis (n = 13, 11.4%), and petechiae (n = 9, 7.89%). Patients with bleeding, particularly petechiae, ecchymosis, epistaxis, and gum bleeding, had significantly lower platelet counts than those without bleeding symptoms. Conclusion Infections were the predominant cause of thrombocytopenia in this cohort. Lower platelet counts were significantly associated with bleeding manifestations, particularly epistaxis, emphasizing the need for early recognition and appropriate clinical management.

thrombocytopeniaetiologyclinical featuresinfection
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Parental Attitudes Toward Childhood Vaccination in Riyadh, Saudi Arabia: A Cross-Sectional Study

Cureus · مجلد 18 (4) · e107631-e107631

Background Parental attitudes toward childhood vaccination play a critical role in vaccine uptake. Several factors can influence parental attitudes regarding vaccination. This study aimed to assess parental attitudes toward childhood vaccination in Riyadh, Saudi Arabia, and examine the influence of sociodemographic factors. Methodology A cross-sectional study was conducted among parents residing in Riyadh using an online, self-administered questionnaire distributed via social media platforms. The survey instrument was based on the Vaccine Attitudes Examination scale and consisted of 11 Likert-scale items. Data were analyzed using SPSS version 28. Results A total of 469 parents participated. Most respondents were female (n = 286, 61.0%), aged 25-44 years (n = 257, 54.8%), married (n = 402, 85.7%), and held a bachelor's degree (n = 267, 56.9%). Positive perceptions of vaccination were common, as 58.5% (n = 274) agreed or strongly agreed that they felt safe after vaccination, and 65.7% (n = 308) agreed or strongly agreed that vaccines prevent serious infectious diseases. Most participants also valued reliable information sources, with 81.2% (n = 381) agreeing or strongly agreeing that accurate information supports informed decisions. However, concerns persisted regarding unforeseen side effects and beliefs favoring natural immunity over vaccination. Overall, most participants demonstrated neutral attitudes (n = 348, 74.2%), followed by negative attitudes (n = 83, 17.7%) and positive attitudes (n = 38, 8.1%). Gender (p = 0.022) and employment status (p = 0.032) were significantly associated with attitudes. In multivariable analysis, female gender (odds ratio (OR) = 2.113, 95% confidence interval (CI) = 1.227-3.640, p = 0.007), larger family size (OR = 1.538, 95% CI = 1.043-2.269, p = 0.030), and employment status (OR = 1.299, 95% CI = 1.005-1.680, p = 0.046) significantly predicted negative attitudes. Conclusions Most parents in Riyadh demonstrated neutral attitudes toward childhood vaccination, while nearly one in five showed negative attitudes. Targeted educational strategies addressing safety concerns and misinformation may help strengthen vaccine confidence among parents.

parental attitudeschildhood immunizationvaccine hesitancyvaccine uptake
مراجعةوصول مفتوح20261استشهاد· Semantic Scholar

Efficacy of Selective Serotonin Reuptake Inhibitors for the Treatment of Chronic Pain and Comorbid Depression in Individuals With Fibromyalgia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Cureus · مجلد 18 (2) · e102998-e102998

Fibromyalgia causes symptoms like chronic widespread pain, fatigue, and cognitive difficulties, often alongside depression and chronic pain, complicating treatment. While selective serotonin reuptake inhibitors (SSRIs) are prescribed for fibromyalgia-related depression and pain, their effectiveness is unclear. This systematic review and meta-analysis evaluated SSRI efficacy in fibromyalgia patients with comorbid depression and chronic pain. This systematic review was registered with the International Prospective Register of Systematic Reviews (PROSPERO) and conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. We searched PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, Ovid, and Google Scholar. We included randomized controlled trials (RCTs) using formal fibromyalgia criteria and reporting depression or pain outcomes. Non-RCTs, studies with non-adults, or non-SSRI comparisons without isolating SSRI effects were excluded. The Cochrane risk-of-bias tool for randomized trials (RoB-2) was used to assess the risk of bias in this study. Four reviewers independently screened titles and abstracts; four assessed full-texts with disagreements resolved by a senior reviewer. Outcome data were converted to mean change scores from baseline where not directly reported. The standardized mean difference (SMD) was used for the meta-analysis to pool data across different scales. Nine RCTs (n = 461 participants, predominantly female, mean ages across studies ranged from 32.7 to 52.9 years) were analyzed. Compared to placebo, SSRIs significantly reduced pain (eight RCTs, n = 421; SMD -0.53, 95% confidence interval (CI): -0.92 to -0.14, p = 0.007) and improved depression (six RCTs, n = 265; SMD -0.67, 95% CI: -1.14 to -0.20, p = 0.005). SSRIs also significantly improved quality of life (QOL) versus placebo (five RCTs, n = 301; SMD -0.30, 95% CI: -0.55 to -0.04, p = 0.02). Compared to other non-pharmacological interventions (acupuncture and aerobic exercise), SSRIs showed non-significant improvement in depression (two RCTs, n = 70; SMD -0.39, 95% CI: -1.32 to 0.54, p = 0.41). Common side effects included gastrointestinal issues, dry mouth, sedation, sexual dysfunction, and headaches; SSRI groups reported more adverse events and higher dropout rates. SSRIs showed statistically significant benefits for pain, depression, and QOL in fibromyalgia compared to placebo. However, the overall evidence quality was found to be very low to low due to heterogeneity and risk of bias. Future RCT designs should adhere to a strict methodology in order to strengthen the available evidence on the efficacy of SSRIs in treating fibromyalgia.

fibromyalgiaselective serotonin reuptake inhibitorscomorbid depressionchronic widespread pain
مقالوصول مفتوح2026

Isolated Proximal Muscle Myopathy and Generalized Fatigability Associated with Severe Zinc Deficiency Following Sleeve Gastrectomy: A Case Report

Cureus

Zinc is a vital micronutrient that plays a role in many bodily functions, such as controlling the immune system, making proteins, and breaking down cells.Zinc deficiency is commonly acknowledged in postbariatric patients; however, its manifestation as isolated myopathy without typical dermatological signs is rare and may impede timely diagnosis.We report the case of a 49-year-old woman who presented with a five-month history of progressive generalized fatigue and proximal muscle weakness, resulting in a significant impairment of her activities of daily living.Her past medical history was significant for laparoscopic sleeve gastrectomy five years ago with reported compliance with routine multivitamin supplementation.On clinical examination, the muscle strength was decreased (4/5) without sensory deficits or cutaneous abnormalities.The initial laboratory work-up, including hematologic, metabolic, endocrine, and autoimmune studies, was essentially unremarkable except for an elevated erythrocyte sedimentation rate.Further work-up for trace elements revealed a significantly low serum zinc level with other minerals within normal limits.A diagnosis of myopathy due to severe zinc deficiency was made.The patient received oral zinc supplementation, resulting in complete clinical recovery and normalization of zinc levels within four months.This case demonstrates a unique manifestation of zinc deficiency presenting as isolated proximal myopathy in a post-sleeve gastrectomy patient, years after surgery and without classical features.It stresses the importance of evaluating trace element deficiencies in the differential diagnosis of unexplained neuromuscular symptoms and supports the need for long-term nutritional monitoring after bariatric procedures.

zinc deficiencysleeve gastrectomybariatric surgery complicationsmuscle weakness
مقالوصول مفتوح2026

Knowledge, Attitudes, and Use of Antidiabetic Medications for Weight Loss Among Adults in Riyadh, Saudi Arabia: A Cross-Sectional Study

Cureus

BackgroundThe increasing use of anti-diabetic drugs, particularly glucagon-like peptide-1 receptor agonists (GLP-1 RAs), for weight loss has prompted concerns about public awareness, attitudes, and usage.In Saudi Arabia, a substantial proportion of adults have obesity or are overweight, highlighting the considerable burden of obesity.Meanwhile, the increasing use of GLP-1 RAs for weight management underscores the importance of assessing public knowledge and attitudes toward these medications. ObjectiveThe objective of this study is to assess knowledge, attitudes, and practices regarding antidiabetic medications used for weight loss among adult residents of Riyadh, Saudi Arabia. MethodsThe cross-sectional survey included 282 adult residents of Riyadh.A self-administered electronic questionnaire was sent using a non-probability convenience sampling method.The questionnaire evaluated sociodemographic variables, knowledge, attitudes, and practices about antidiabetic medicines used for weight loss.Data were analyzed using nonparametric tests, Spearman's ρ correlation, and multivariable linear and binary logistic regression analyses. ResultsOf the 282 participants, 70.9% were female and 68.4% were married.The median knowledge score was 15.0 (interquartile range (IQR), 12.0-18.0),and the median attitude score was 23.0 (IQR, 21.0-25.0).Knowledge and attitude scores showed a weak positive correlation (Spearman's ρ = 0.254, p < 0.001).Overall, 76 participants (27.0%) reported using antidiabetic medications for weight reduction, with Ozempic (55.3%) and Mounjaro (44.7%) being the most commonly used medications.Female gender was independently associated with higher knowledge scores, whereas non-medical occupation was associated with lower knowledge and attitude scores.Participants with chronic disease had higher odds of weight-loss medication use, whereas higher attitude scores were associated with lower odds of use. ConclusionAdults in Riyadh demonstrated important knowledge gaps regarding weight-loss medications.Knowledge and attitudes varied by occupation, while medication use was independently associated with chronic disease status and attitude scores, highlighting the need for evidence-based education and medically supervised use.

antidiabetic drugsweight lossGLP-1 receptor agonistsobesity
مراجعةوصول مفتوح2026

Rifaximin Versus Placebo for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Cureus · مجلد 18 (9) · e116820-e116820

Rifaximin, a minimally absorbed broad-spectrum oral antibiotic, is used to target gut dysbiosis in patients with irritable bowel syndrome (IBS).However, conflicting trial data and methodological heterogeneity necessitate an updated, rigorous synthesis of its efficacy and safety profile.We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing rifaximin with placebo in adult patients with IBS, adhering to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 guidelines.The primary outcome was global symptom relief at the end of the treatment.Data were pooled using inverse-variance random-effects models with Hartung-Knapp-Sidik-Jonkman (HKSJ) adjustment.Evidence robustness was evaluated using prediction intervals (PI), Trial Sequential Analysis (TSA), trim-and-fill algorithms for publication bias, and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology.Nine RCTs (yielding 10 randomized comparisons due to one trial's a priori stratification by small intestinal bacterial overgrowth status) were included in this review.For the primary outcome (eight comparisons, N=2,056), rifaximin significantly improved global symptom relief compared to placebo (RR 1.54, 95% CI 1.13 to 2.11; p=0.014), corresponding to a number needed to treat for benefit (NNTB) of 6.However, statistical heterogeneity was substantial (I 2 =59.5%), and the 95% PI crossed the line of no effect (0.89-2.67).The primary effect lost statistical significance upon the exclusion of high-risk-of-bias trials (RR 1.47, 95% CI 0.95-2.27)and after adjusting for publication bias using the trim-and-fill method (RR 1.37, 95% CI 0.93-2.01).The TSA indicated that the accrued information size remained inconclusive for a conservative 15% relative benefit.Rifaximin demonstrated no statistically detectable difference in adverse events compared to placebo, though this is accompanied by considerable uncertainty (Peto OR 0.89 (95% CI 0.65-1.22)).Rifaximin demonstrates a modest overall benefit for global IBS symptoms and an excellent safety profile; however, the certainty of evidence is very low.The apparent efficacy is highly fragile, driven largely by industry-funded trials, undermined by publication bias, and characterized by wide prediction intervals.Biomarker-guided stratification, such as testing for small intestinal bacterial overgrowth (SIBO), may be required to optimize patient selection in future independent trials.

rifaximinirritable bowel syndromeplacebo comparisonantibiotic therapy
مراجعةوصول مفتوح2026

Comparative Effectiveness of Nonoperative Treatments for Acute Anterior Epistaxis in Emergency and Otolaryngology Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Cureus · مجلد 18 (8) · e115154-e115154

Acute anterior epistaxis is frequently managed with multiple nonoperative interventions, but comparative evidence regarding their effectiveness remains uncertain. This systematic review and meta-analysis evaluated the effectiveness and safety of nonoperative treatments for acute anterior epistaxis in emergency and otolaryngology settings. PubMed/MEDLINE, Scopus, and Web of Science were searched from inception through 3 July 2026 for randomized controlled trials (RCTs) comparing nonoperative hemostatic interventions in adults with acute anterior epistaxis. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool, and random-effects meta-analysis was performed when sufficient clinical comparability was present. Nine RCTs including 1,124 participants were identified, with three trials contributing to quantitative synthesis. Topical tranexamic acid reduced rebleeding within 24 hours compared with matched vehicle controls (RR, 0.39; 95% CI, 0.17-0.89), with an absolute risk reduction of 19.1 percentage points. However, topical tranexamic acid was not associated with a significant reduction in further hemostatic intervention (RR, 0.59; 95% CI, 0.22-1.59). Other nonoperative strategies showed variable effects across heterogeneous outcomes. Overall, topical tranexamic acid may reduce early rebleeding in acute anterior epistaxis, but evidence regarding broader clinical outcomes remains limited by the small number of comparable trials, heterogeneous protocols, and inconsistent outcome definitions. Further high-quality randomized trials with standardized outcomes are required to clarify the optimal role of these interventions.

conservative treatmentepistaxis managementemergency department careotolaryngology practice
مراجعةوصول مفتوح2026

Comparison Between High-Flow Nasal Cannula (HFNC) Therapy and Noninvasive Ventilation (NIV) in Children With Bronchiolitis-Associated Acute Respiratory Failure: A Systematic Review and Meta-Analysis

Cureus · مجلد 18 (8) · e114308-e114308

The optimal noninvasive respiratory support for infants and children with severe viral bronchiolitis remains unclear. While continuous positive airway pressure (CPAP) has traditionally been considered the gold standard, high-flow nasal cannula (HFNC) therapy is a better-tolerated alternative. This systematic review and meta-analysis aimed to evaluate the comparative efficacy and safety of HFNC versus noninvasive ventilation (NIV) in pediatric patients with bronchiolitis-associated acute respiratory failure. We searched major electronic databases through June 2026. We included randomized controlled trials (RCTs) and observational cohorts comparing HFNC with NIV (CPAP/bilevel positive airway pressure (BiPAP)). The primary outcomes were treatment failure, as defined by the individual studies, and endotracheal intubation. Data were synthesized using random-effects models, and heterogeneity was explored via subgroup analysis and meta-regression. Eleven studies (seven RCTs and four observational studies) comprising 7,574 patients were included. There was no statistically significant difference in the overall risk of treatment failure between HFNC and NIV (RR 1.99, 95% CI 0.65-6.10); however, study design was a significant moderator (p = 0.0019). Observational studies reported significantly higher failure rates with HFNC (RR 7.78), whereas RCTs showed no significant difference (RR 1.11). There were no significant differences in endotracheal intubation rates (RR 0.75, 95% CI 0.51-1.09) or pediatric intensive care unit length of stay (MD -0.16 days, 95% CI -0.79 to 0.47) between the groups. HFNC demonstrated a trend toward fewer local adverse events, such as nasal/skin trauma (RR 0.30, 95% CI 0.06-1.52), than did NIV. The certainty of evidence according to GRADE was low for all outcomes. HFNC showed no significant differences from NIV in critical clinical endpoints, including intubation rates and intensive care duration. Differences in treatment failure rates appeared to be influenced by study design, highlighting potential confounding by indication in observational data. Given its improved tolerability and trend toward reduced mucosal trauma, HFNC may represent a viable first-line noninvasive intervention for pediatric bronchiolitis.

high-flow nasal cannulanon-invasive ventilationpediatric bronchiolitisacute respiratory failure
مراجعةوصول مفتوح2026

Comparative Effectiveness of Antihypertensive Agents vs. Control in the Prevention and Management of Preeclampsia: A Network Meta-Analysis

Cureus · مجلد 18 (5) · e109602-e109602

Hypertensive disorders of pregnancy, particularly preeclampsia, are a leading cause of maternal and perinatal morbidity. While antihypertensive therapy is recommended, clinical uncertainty persists regarding the optimal agent to maximize maternal safety while minimizing adverse neonatal outcomes such as neonatal intensive care unit (NICU) admission. This review aimed to evaluate the comparative effectiveness and safety of pharmacological antihypertensive agents versus standard care or placebo in the management of hypertensive disorders of pregnancy through a network meta-analysis (NMA). A systematic review and frequentist random-effects NMA of randomized controlled trials (RCTs) was conducted. Major databases were searched for RCTs comparing antihypertensive agents (labetalol, nifedipine, methyldopa, hydralazine, prazosin) and controls. The primary neonatal outcome evaluated in this network was NICU admission. Risk of bias was assessed using the Cochrane RoB 2 tool, and the certainty of evidence was evaluated using the GRADE framework. Twenty-five RCTs were included in the qualitative and quantitative synthesis. The network geometry was anchored by labetalol and nifedipine. In the NMA, no individual antihypertensive agent demonstrated a statistically significant reduction in the risk of NICU admission compared to labetalol. However, probabilistic ranking (P-scores) identified methyldopa (P-score = 0.859) and hydralazine (0.791) as the most favourable interventions for minimizing NICU admissions. Nifedipine showed a slightly elevated, though non-significant, risk profile compared to labetalol (RR 1.09, 95% CI 0.80-1.49). The placebo and standard care ranked lowest. The overall certainty of evidence ranged from moderate to very low due to imprecision and indirectness. Active pharmacological management of hypertension in pregnancy is superior to placebo or standard care. While labetalol and nifedipine remain mainstays for acute blood pressure control, methyldopa and hydralazine probabilistically rank higher for minimizing NICU admissions. These findings support individualized antihypertensive selection based on clinical acuity and maternal-fetal hemodynamics.

preeclampsiahypertensive disorders of pregnancyantihypertensive drugslabetalol
مراجعةوصول مفتوح2026

Therapeutic Outcomes of Janus Kinase Inhibitors in Refractory Nail Lichen Planus: A Systematic Review

Cureus · مجلد 18 (5) · e108953-e108953

Nail lichen planus (NLP) is a chronic immune-mediated inflammatory disorder and one of the most challenging forms of lichen planus to treat. Conventional therapies, including intralesional corticosteroids, systemic immunosuppressants, and topical agents, are often associated with high failure rates and significant adverse effects. Janus kinase inhibitors (JAKIs) have emerged as mechanistically rational therapeutic agents because of the central role of the interferon (IFN)-JAK-signal transducer and activator of transcription (JAK-STAT) pathway in lichenoid inflammation; however, their efficacy and safety in NLP have not yet been systematically evaluated. A systematic review was conducted by searching PubMed, Scopus, and Web of Science from database inception through March 2026 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Eligible studies included patients with clinically and/or histopathologically confirmed NLP and studies reporting original patient-level data of any design. Risk of bias was assessed using the Joanna Briggs Institute (JBI) critical appraisal tools appropriate to each study design. A cumulative time-to-response model was constructed, and a random-effects meta-analysis of standardized mean change (SMC) in nail severity scores was performed where data permitted. Thirteen studies were included with a total of 25 patients. Interventions included oral and topical tofacitinib, baricitinib, abrocitinib, upadacitinib, and topical ruxolitinib. Clinically meaningful improvement was reported across all studies, with most responses occurring within three to seven months of treatment initiation. The pooled SMC was 1.65 (95% confidence interval (CI): 0-3.59), with substantial heterogeneity (I²=87.6%). No serious adverse events were reported. Overall, JAKIs appear to be effective and well tolerated in the short term for refractory NLP, supporting their potential role as rescue therapy in selected cases. However, the current evidence remains limited and heterogeneous, underscoring the need for prospective randomized controlled trials with standardized outcome measures and longer follow-up durations.

nail lichen planusJAK inhibitorsrefractory lichen planustofacitinib
مراجعةوصول مفتوح20256استشهاد· Semantic Scholar

Efficacy of Gut Microbiome-Targeted Therapies in Modulating Systemic Inflammation and Low-Grade Chronic Inflammatory States in Adults With Metabolic Disorders: A Systematic Review

Cureus · مجلد 17 (9) · e92881-e92881

Gut microbiome-targeted therapies have shown promise in promoting the outcomes of metabolic inflammation-related disease management. This review aims to assess the effectiveness of microbiome-targeted interventions and pinpoint the most promising therapies for clinical implementation. Following the PRISMA 2020 standards, we searched four main databases: PubMed, EMBASE, Scopus, and the Cochrane Library. We integrated medical subject headings (MeSH) and free-text keywords search pertinent to gut microbiome-targeted interventions, along with related outcomes such as inflammation and insulin resistance. English studies were conducted on primary adults with a metabolic disease diagnosis or deemed a high risk, and were mandated to report at least one outcome pertinent to metabolic health or systemic inflammation. To assess the risk bias, data were extracted, and the Cochrane Risk of Bias (RoB) 2.0 tool was employed. Fifteen studies fulfilled the inclusion criteria. A narrative synthesis was conducted. We found that probiotics significantly enhanced insulin resistance (HOMA-IR), reduced circulating endotoxin levels, decreased visceral fat, BMI, and fat mass, and increased beneficial taxa with obesity-associated bacteria reduction. However, inconsistent outcomes were shown for lipid parameters. Prebiotic therapies showed significant decreases in fasting glucose in overweight people, and insulin levels and HOMA-IR in patients with metabolic syndrome, enhanced anti-inflammatory effects (31% C-reactive protein (CRP) reduction, decreased interleukin (IL)-6, tumor necrosis factor-alpha (TNF)-α, and lipopolysaccharide (LPS) levels), and promoted butyrate-producing bacteria. Synbiotic interventions showed complementary benefits for glucose metabolism and body composition. Fecal microbiota transplantation (FMT) studies indicated improved insulin sensitivity and donor microbiota engraftment in responders. Fiber-rich diet trials markedly improved HbA1c levels in diabetic and prediabetic individuals. In conclusion, prebiotics demonstrated the most consistent metabolic and anti-inflammatory benefits across multiple parameters. Probiotics showed targeted effects on insulin resistance and body composition but inconsistent lipid outcomes. FMT and synbiotics require further investigation to establish clinical efficacy. This evidence supports prebiotics as a priority intervention for metabolic disease management through microbiome modulation.

systemic inflammationlow-grade inflammationmetabolic disordersprobiotics
مقالوصول مفتوح20256استشهاد· Semantic Scholar

Awareness of Hepatitis B Among the General Population in Riyadh, Saudi Arabia

Cureus · مجلد 17 (1) · e77437-e77437

BACKGROUND: Hepatitis B, caused by the hepatitis B virus (HBV), remains a significant global public health challenge despite advances in vaccination and treatment. This study aims to evaluate the awareness, knowledge, and perceptions of hepatitis B among the general population in Riyadh, Saudi Arabia. METHODS: A cross-sectional survey was conducted in Riyadh in 2024, involving 805 participants aged 18 years and above. Data were collected using a structured questionnaire that assessed demographic characteristics, general awareness, knowledge of transmission and prevention, testing history, and sources of information. Descriptive statistics and chi-squared tests were used for analysis. RESULTS: Among the participants, 87% reported awareness of hepatitis B, though detailed knowledge about transmission and prevention revealed gaps. Awareness of blood transfusion as a transmission route was high (83.2%), while unprotected sex (49.3%) and mother-to-child transmission (43.2%) were less recognized. Vaccination was identified as a preventive measure by 83.5%, but misconceptions, such as the efficacy of hand washing (32%), were evident. Only 35.4% of participants had been tested for hepatitis B, highlighting low screening rates. Primary information sources included healthcare providers (57.1%) and the internet (57.5%), with social media cited by 41.5%. Gender, age, and educational background significantly influenced knowledge levels. CONCLUSION: While general awareness of hepatitis B is high, critical gaps in detailed knowledge and testing behavior remain. Public health strategies should focus on correcting misconceptions, enhancing screening rates, and leveraging trusted information sources to improve the understanding and management of hepatitis B. This study provides valuable insights for policymakers aiming to bridge these knowledge gaps and enhance disease prevention efforts.

hepatitis Bhepatitis B viruspublic awarenesshealth knowledge
مراجعةوصول مفتوح20253استشهاد· Semantic Scholar

Machine Learning Applications Beyond Outcome Prediction in Plastic and Reconstructive Surgery: A Systematic Review of Diagnostic, Intraoperative, and Workflow Optimization Models

Cureus · مجلد 17 (10) · e94825-e94825

Plastic and reconstructive surgery increasingly depends on data-driven instruments to improve clinical decision-making. Machine learning (ML), through its capacity to analyze intricate, high-dimensional data, presents novel prospects for forecasting surgical outcomes with enhanced accuracy compared to traditional statistical models. This systematic study evaluates the extent, efficacy, and methodological rigor of ML applications in plastic and reconstructive surgery, encompassing burn treatment, microsurgical reconstruction, and breast surgery. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 standards, we searched four main databases for research published between January 2015 and March 2025. Eligible papers used ML models to predict clinical outcomes in plastic or reconstructive surgery and provided quantifiable performance indicators. Data were retrieved using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies (CHARMS) and Prediction Model Risk of Bias Assessment Tool (PROBAST) frameworks, then synthesized narratively. We included eleven studies that had more than 34,000 patients. Random forests, neural networks, and gradient boosting have emerged as the most prevalent and highest-performing models, with several attaining AUCs exceeding 0.90. Notwithstanding encouraging outcomes, the majority of research depended on internal validation, with only one performing external validation. Calibration reporting and data transparency were constrained. The majority of studies exhibited a high or moderate risk of bias. In summary, ML models provide significant prediction accuracy in plastic surgery; yet, they are limited by methodological deficiencies that impede clinical implementation. Future initiatives must prioritize external validation, repeatability, and ethical execution to facilitate the safe and successful incorporation into surgical practice.

machine learningplastic surgerysurgical outcome predictionburn treatment